US$ 29.43
wegovy glp 1 agonist MHRA approves GLP–1 receptor for new use | Pharmaceutical Compare GLP-1 Options | Ozempic
Description
ArticlePubMed 55

A recent case-control study of 1,961 new GLP-1RA patients showed that use of GLP-1RAs significantly reduced the risk of glaucoma, with a hazard ratio of 0.56 [94]

[DOI] [PubMed] [Google Scholar] 200.Do D., Lee T., Inneh A., Patel U
Originally developed to treat diabetes, GLP-1 medications like Wegovy have exploded in popularity

For a full breakdown of how GLP-1 side effects interact with other medicines, see Part 5: GLP-1 Side Effects for Indians

Acta Endocrinol (Buchar)